This topic contains a solution. Click here to go to the answer

Author Question: Martin and Matthew are identical twins. Matthew has obsessive-compulsive disorder, but Martin does ... (Read 85 times)

Yi-Chen

  • Hero Member
  • *****
  • Posts: 550
Martin and Matthew are identical twins. Matthew has obsessive-compulsive disorder, but Martin does not. In a biological research study, who would be the proband?
 
  a. Martin
 b. Matthew
 c. Martin and Matthew's mother
 d. Martin and Matthew's older sister

Question 2

In a genetic linkage study, which piece of information would be important?
 
  a. whether behavior changes when individuals are exposed to a particular chemical or diet
  b. whether the experimenter knows who is in the experimental group
 c. the nationwide prevalence of the disorder under study
 d. identifying family members who have the same disorder as the proband



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lindahyatt42

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

b

Answer to Question 2

d




Yi-Chen

  • Member
  • Posts: 550
Reply 2 on: Jun 22, 2018
:D TYSM


Animal_Goddess

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library